[{"Assets_0_Q3_USD":24934100000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":163400000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":156900000.0,"EarningsPerShareBasic_3_Q3_USD":22.29,"EarningsPerShareBasic_1_Q3_USD":4.47,"StockholdersEquityConverted_0_Q3_USD":10744500000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":163700000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":157200000.0,"StockholdersEquity_0_Q3_USD":10758500000.0,"RevenuesConverted_3_Q3_USD":10592000000.0,"RevenuesConverted_1_Q3_USD":3376100000.0,"NetIncomeLossConverted_3_Q3_USD":3642700000.0,"NetIncomeLossConverted_1_Q3_USD":701500000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":4596900000.0,"EarningsPerShareDiluted_1_Q3_USD":4.46,"EarningsPerShareDiluted_3_Q3_USD":22.25,"Ticker":"BIIB","CIK":"875045","name":"BIOGEN INC.","OfficialName":"Biogen Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"32775642095.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20201021"}]